BARCLAYS PLC - STRONGBRIDGE BIOPHARMA PLC ownership

STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 72 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of STRONGBRIDGE BIOPHARMA PLC
ValueSharesWeighting
Q3 2021$14,000
-90.5%
6,969
-86.0%
0.00%
Q2 2021$148,000
+45.1%
49,839
+35.4%
0.00%
Q1 2021$102,000
+200.0%
36,807
+159.0%
0.00%
Q4 2020$34,000
-2.9%
14,212
-13.8%
0.00%
Q3 2020$35,000
-52.7%
16,478
-16.8%
0.00%
Q2 2020$74,000
+221.7%
19,797
+65.0%
0.00%
Q1 2020$23,000
-70.1%
12,001
-67.6%
0.00%
Q4 2019$77,000
+67.4%
37,077
+91.5%
0.00%
Q3 2019$46,000
-57.4%
19,359
-43.9%
0.00%
Q2 2019$108,000
-10.0%
34,519
+43.2%
0.00%
Q1 2019$120,000
+11900.0%
24,106
+11601.9%
0.00%
Q4 2018$1,000
-99.7%
206
-99.7%
0.00%
Q3 2018$350,000
+4.5%
72,240
+29.5%
0.00%
Q2 2018$335,000
+78.2%
55,771
+164.2%
0.00%
Q1 2018$188,000
+571.4%
21,109
+429.8%
0.00%
Q4 2017$28,000
+600.0%
3,984
+640.5%
0.00%
Q3 2017$4,000538
+3064.7%
0.00%
Q2 2017$0
-100.0%
17
-99.9%
0.00%
Q1 2017$73,00015,3140.00%
Other shareholders
STRONGBRIDGE BIOPHARMA PLC shareholders Q4 2020
NameSharesValueWeighting ↓
CAXTON CORP 5,376,039$47,309,00051.34%
Lyon Street Capital, LLC 3,182,149$28,162,0009.07%
Opaleye Management Inc. 1,590,000$14,071,0004.02%
Broadfin Capital, LLC 2,793,752$24,725,0003.85%
Vivo Capital, LLC 1,918,132$16,975,0002.40%
ARMISTICE CAPITAL, LLC 3,372,000$29,842,0002.28%
PRECEPT MANAGEMENT LLC 470,000$4,160,0001.73%
NEA Management Company, LLC 4,141,308$36,651,0001.63%
Harvest Capital Strategies LLC 825,000$7,301,0001.14%
Granite Point Capital Management, L.P. 567,895$5,026,0000.49%
View complete list of STRONGBRIDGE BIOPHARMA PLC shareholders